Pulmocide recently completed a Phase 2 safety and tolerability clinical trial (OPERA-S study) in lung transplant patients receiving inhaled opelconazole monotherapy as prophylaxis against pulmonary ...

Dr. Andy Whittamore, a GP and clinical lead at Asthma and Lung UK, shed light on four chronic lung conditions that tend to ...

As columnist Charlene Marshall looks ahead to 2025, she shares some of her New Year's wishes for fellow pulmonary fibrosis patients.

Women are less likely to receive a lung transplant and spend an average of six weeks longer on the waiting list, according to ...

Women who receive a lung transplant are more likely than men to live for five years post-transplant, according to new ...

Increased delay to lung transplantation for women candidates: gender-based disparity matters in the lung transplant ...

Contineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...

In a report released today, Emily Field from Barclays maintained a Hold rating on Galapagos (0JXZ – Research Report), with a price target of ...

Verona Pharma (NASDAQ:VRNA – Get Free Report) had its price target raised by investment analysts at Wells Fargo & Company ...

People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

A group of Australian schoolgirls have been lashed for mocking Liam Payne’s death in an “absolutely disgusting” viral video. Liam Payne’s ex-fiancée Maya Henry wrote about a perilous ...